참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Piperazine | HCID 4837 | — |
| 반응물 | Methyl iodide | HCID 6328 | — |
| 반응물 | 2-Chlorodibenz(b,f)-1,4-oxazepin-11(10H)-one | HCID 76619 | — |
| 반응물 | Lawesson's reagent | HCID 87949 | — |
| 용매 | Toluene | HCID 1140 | — |
| 생성물 | 8-Chloro-11-(piperazin-1-yl)-dibenzo[b,f][1,4]oxazepine | HCID 11738520 | 57% |
반응 단계
A mixture of 8-chloro-10H-dibenzo[b,f][1,4]oxazepin-11-one (189JO29C) (17 mg, 0.069 mmol) and 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide (16 mg, 0.040 mmol) in toluene (2 mL) was heated in capped tube using microwave assisted heating (130° C., 20 minutes). The reaction mixture was cooled to room temperature and MeI (18 μL, 0.29 mmol) was added and the resulting mixture was heated in capped tube using microwave assisted heating (120° C., 20 minutes). The mixture was concentrated and the residue was taken up in pyridine (2 mL) and piperazine (25 mg, 0.29 mmol) was added. The resulting mixture was heated in a capped tube at 130° C. over night then using microwave assisted heating (160° C., 30 minutes). The mixture was concentrated, diluted with EtOAc and washed with water. The organic phase was applied onto a SCX-2 ion exchange column. The column was washed with MeOH, and then the product was eluted with NH3 (7 N in MeOH) to give 9.0 mg (57%) of the title compound (189JO31). MS (ESI) 314 (MH+). Purity for MH+ (UV/MS) 92/100.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07622461B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_11 |
|---|
| ORD ID | ord-bbf1d306e0e8406a82cfaa75ef292e48 |
|---|
| 출처 메모 | uspto-grants-2009_11 |
|---|